The frequency of global crises such as hurricanes, war, and the pandemic makes a standing committee necessary.
The Community Oncology Alliance (COA) has launched a new standing Humanitarian Aid Committee, which will coordinate aid for those affected by war, natural disasters, and other crises. The group’s first effort will be supporting 4 medical charities that are assisting those affected by the war in Ukraine: Americares, Direct Relief, Doctors Without Borders, and International Medical Corps. A webpage for the committee can be found here.
A statement from COA released Monday says that although the group’s mission is based in the United States, “the greater oncology community has a responsibility to act and engage on a global scale during times of crisis.” COA has worked with other groups on hurricane relief efforts and on the global effort to keep patients safe during the COVID-19 pandemic.
The frequency of such events makes a standing committee necessary, the group said.
“Cancer isn’t localized to one country or region of the world, and it certainly doesn’t become less important during times of crisis,” said Mark Thompson, MD, COA’s medical director of public policy. “As people are displaced and seek shelter, it’s our responsibility to help them continue treatment. Cancer doesn’t stop during an emergency. COA’s mission to fight cancer doesn’t either.”
The Humanitarian Aid Committee will include both volunteers and staff. Current members include:
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Margin Status Likely Not a Factor in STS Recurrence
May 10th 2024The optimal negative margin required following surgical resection and perioperative radiotherapy for extremity soft tissue sarcoma (STS) remains up for debate, with investigators of a new study using Union for International Cancer Control classification to define resection margin.
Read More